On a scale of 0 to 100, ABIVAX Socit holds a performance score of 5. The firm shows a Beta (market volatility) of 0.3642, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, ABIVAX Socit returns are expected to increase less than the market. However, during the bear market, the loss on holding ABIVAX Socit will be expected to be smaller as well. By evaluating ABIVAX Socit Anonyme technical indicators, you can at this time evaluate if the expected return of 0.2% will be sustainable into the future. Please makes use of ABIVAX Socit Anonyme coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and day typical price to make a quick decision on whether ABIVAX Socit price patterns will revert.
5 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in ABIVAX Socit Anonyme are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating basic indicators, ABIVAX Socit may actually be approaching a critical reversion point that can send shares even higher in October 2023. ...more
|Begin Period Cash Flow||29.3 M|
|Total Cashflows From Investing Activities||-1.5 M|
ABIVAX Socit Relative Risk vs. Return LandscapeIf you would invest 1,650 in ABIVAX Socit Anonyme on June 23, 2023 and sell it today you would earn a total of 171.00 from holding ABIVAX Socit Anonyme or generate 10.36% return on investment over 90 days. ABIVAX Socit Anonyme is currently producing 0.1978% returns and takes up 2.941% volatility of returns over 90 trading days. Put another way, 25% of traded pink sheets are less volatile than ABIVAX, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Assuming the 90 days horizon ABIVAX Socit is expected to generate 4.83 times more return on investment than the market. However, the company is 4.83 times more volatile than its market benchmark. It trades about 0.07 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.03 per unit of risk.
ABIVAX Socit Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ABIVAX Socit's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as ABIVAX Socit Anonyme, and traders can use it to determine the average amount a ABIVAX Socit's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
ABIVAX Socit Fundamentals Growth
ABIVAX Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of ABIVAX Socit, and ABIVAX Socit fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ABIVAX Pink Sheet performance.
About ABIVAX Socit Performance
Things to note about ABIVAX Socit Anonyme performance evaluationChecking the ongoing alerts about ABIVAX Socit for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for ABIVAX Socit Anonyme help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions. Evaluating ABIVAX Socit's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate ABIVAX Socit's pink sheet performance include:
- Analyzing ABIVAX Socit's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ABIVAX Socit's stock is overvalued or undervalued compared to its peers.
- Examining ABIVAX Socit's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ABIVAX Socit's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ABIVAX Socit's management team can help you assess the company's leadership.
- Pay attention to analyst opinions and ratings of ABIVAX Socit's pink sheet. These opinions can provide insight into ABIVAX Socit's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABIVAX Socit Anonyme. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in banks. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for ABIVAX Pink Sheet analysis
When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.